- Home
- ACIU vs CIA Comparison
ACIU vs CIA Comparison
Compare ACIU & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACIU | CIA |
|---|---|---|
| Founded | 2003 | 1969 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 251.0M |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ACIU | CIA |
|---|---|---|
| Price | $3.32 | $4.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 329.8K | 122.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $255,616,000.00 |
| Revenue This Year | $635.38 | $2.83 |
| Revenue Next Year | $232.58 | $5.16 |
| P/E Ratio | ★ N/A | $28.23 |
| Revenue Growth | N/A | ★ 4.33 |
| 52 Week Low | $1.43 | $2.90 |
| 52 Week High | $4.00 | $6.40 |
Technical Indicators
Market Signals| Indicator | ACIU | CIA |
|---|---|---|
| Relative Strength Index (RSI) | 60.92 | 38.12 |
| Support Level | $3.18 | $3.34 |
| Resistance Level | $3.92 | $5.44 |
| Average True Range (ATR) | 0.21 | 0.39 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 92.42 | 27.66 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.